Table 3.

Area under the receiver operator characteristics analysis of model of end-stage liver disease score and of calculated models according to the results of multivariate Cox regression in 213 patients with refractory ascites and 88 patients undergoing transjugular intrahepatic portosystemic stent shunt for variceal bleeding.

	Calculated predictors – AUROC (95% CI)		MELD – AUROC (95% CI)
	Refractory ascites	Variceal bleeding	Refractory ascites	Variceal bleeding	P value*
3 months	0.660 (0.558–0.761)	0.876 (0.802–0.950)	0.543 (0.445–0.641)	0.836 (0.730–0.941)	<0.001
1 year	0.665 (0.586–0.744)	0.835 (0.749–0.921)	0.533 (0.449–0.617)	0.767 (0.659–0.875)	<0.001
3 year	0.693 (0.623–0.764)	0.827 (0.739–0.915)	0.629 (0.541–0.717)	0.744 (0.627–0.860)	0.12
5 year	0.691 (0.622–0.761)	0.849 (0.767–0.932)	0.627 (0.520–0.734)	0.702 (0.567–0.838)	0.39

*Significance of the difference between area under the receiver operator characteristics of both patient groups undergoing transjugular intrahepatic portosystemic stent shunt for refractory ascites versus variceal bleeding.

AUROC, area under the receiver operator characteristics; MELD, model of end-stage liver disease.